Sila Realty Trust Files 8-K for Regulation FD Disclosure
Ticker: SILA · Form: 8-K · Filed: Nov 5, 2024 · CIK: 1567925
Sentiment: neutral
Topics: 8-K, disclosure, regulation-fd
TL;DR
Sila Realty Trust filed an 8-K for a Reg FD disclosure. Details TBD.
AI Summary
Sila Realty Trust, Inc. filed an 8-K on November 5, 2024, to report a Regulation FD Disclosure. The filing does not contain specific details about the nature of the disclosure, but it is a current report required by the SEC.
Why It Matters
This filing indicates Sila Realty Trust is making a public disclosure under Regulation FD, which ensures fair and timely dissemination of material information to all investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure and does not inherently present new risks.
Key Numbers
- 001-42129 — SEC File Number (Identifies the company's filings with the SEC.)
- 46-1854011 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Sila Realty Trust, Inc. (company) — Registrant
- November 5, 2024 (date) — Filing Date
- Regulation FD (regulation) — Disclosure Type
- 1001 Water St. Suite 800 Tampa, Florida 33602 (address) — Principal Executive Offices
- Carter Validus Mission Critical REIT II, Inc. (company) — Former Company Name
FAQ
What specific information is being disclosed under Regulation FD?
The provided text of the 8-K filing does not specify the content of the Regulation FD disclosure.
When was this 8-K filing submitted?
The 8-K filing was submitted on November 5, 2024.
What is the principal business address of Sila Realty Trust, Inc.?
The principal executive offices are located at 1001 Water St. Suite 800, Tampa, Florida 33602.
What was Sila Realty Trust, Inc. formerly known as?
The company was formerly known as Carter Validus Mission Critical REIT II, Inc.
What is the state of incorporation for Sila Realty Trust, Inc.?
Sila Realty Trust, Inc. is incorporated in Maryland.
Filing Stats: 1,063 words · 4 min read · ~4 pages · Grade level 12.7 · Accepted 2024-11-05 16:31:08
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share SILA New York Stock
Filing Documents
- cik0001567925-20241105.htm (8-K) — 30KB
- 0001567925-24-000097.txt ( ) — 156KB
- cik0001567925-20241105.xsd (EX-101.SCH) — 2KB
- cik0001567925-20241105_lab.xml (EX-101.LAB) — 22KB
- cik0001567925-20241105_pre.xml (EX-101.PRE) — 13KB
- cik0001567925-20241105_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. Steward Health Care System Update As previously disclosed, on May 6, 2024, Steward Health Care System LLC ("Steward"), the sponsor and owner of a tenant at the Stoughton Healthcare Facility, announced that it filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code. On September 19, 2024, the U.S. Bankruptcy Court for the Southern District of Texas approved Steward's request to reject Sila Realty Trust, Inc.'s (the "Company") lease. On August 12, 2024, the Company entered into a contract for sale with a buyer for the Stoughton Healthcare Facility; however, the buyer terminated the contract on November 4, 2024. The Company intends to market the property for sale or lease. GenesisCare Update As previously disclosed, GenesisCare USA, Inc. and its affiliates ("GenesisCare"), the sponsor and owner of the tenant in certain of the Company's real estate properties, announced that it filed for Chapter 11 bankruptcy protection under the United States Bankruptcy Code on June 1, 2023 and emerged from bankruptcy on February 16, 2024. On October 24, 2024, the Company entered into a contract for sale with a buyer for the Yucca Valley Healthcare Facility, which was previously leased to GenesisCare. The contract is subject to certain terms and conditions as set forth in the contract, and is, among other things, subject to termination by the purchaser during the due diligence period. Based upon the terms in the contract, the sale is anticipated to close in 2024, however, there is no assurance that the sale will be consummated in the time and manner as set forth in the contract. The information furnished under Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be deemed to be incorporated by reference into any filing under the E
Forward-Looking Statements
Forward-Looking Statements Certain statements contained herein, other than historical fact, may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provided by the same. These statements, including statements about the anticipated closing of the sale of the Yucca Valley Healthcare Facility and the Company's intent to market the Stoughton Healthcare Facility for sale or lease, are based on management's current expectations and beliefs and are subject to a number of trends and uncertainties. No forward-looking statement is intended to, nor shall it, serve as a guarantee of future performance. You can identify the forward-looking statements by the use of words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "outlook," "plan," "potential," "predict," "project," "seek," "should," "will" and other similar terms and phrases. Forward-looking statements are subject to various risks and uncertainties and factors that could cause actual results to differ materially from the Company's expectations, and you should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond the Company's control and could materially affect the Company's results of operations, financial condition, cash flows, performance or future achievements or events. Additional factors include those described under the section entitled Item 1A. "Risk Factors" of Part I of the Company's 2023 Annual Report on Form 10-K and those described under the section entitled Item 1A. "Risk Factors" of Part II of the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, copies of which are available at www.sec.gov. The Company undertakes no obligation to publicly update or rev